«S-Adenosylmethionine

Below is an extended S-Adenosylmethionine news listing. Click here to return to the S-Adenosylmethionine main in depth entry.

BioNews Results for S-Adenosylmethionine:
Multiplex Gene Expression HD2 12x135K Microarrays now available from Roche NimbleGen GenomicsProteomics.com:  Aug 30 2008 2:18AM Matching: s
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Preven KRON4:  Aug 29 2008 10:20AM Matching: s
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Preven KOTA Territory News:  Aug 29 2008 5:59AM Matching: s
Pilot Study of Combination Chemotherapy Using Irinotecan plus S-1 for Metastatic Pancreatic Cancer Oncology:  Aug 29 2008 12:54AM Matching: s
IRIS reconstruction implants Nature:  Aug 29 2008 11:56AM Matching: s
Protein Arrays: Study results from University of California in the area of protein arrays published NewsRX:  Aug 29 2008 1:51AM Matching: s
Exposure to antipsychotics and risk of stroke: self controlled case series study British Medical Journal:  Aug 29 2008 1:13AM Matching: s
Multiplex Gene Expression HD2 12x135K Microarrays Now Available from Roche NimbleGen Wis Business.com:  Aug 29 2008 12:12AM Matching: s
PROFESS trial published: Combination therapy falls short of noninferiority vs clopidogrel Theheart.org:  Aug 29 2008 12:12AM Matching: s
Plastic Surgery Portals Miller Teams Up with Top Cleveland Surgeon I-Newswire:  Aug 29 2008 12:11AM Matching: s
GCSE results in full Lytham St Annes Express:  Aug 28 2008 10:34PM Matching: s
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Preven Pharma Live:  Aug 28 2008 12:55PM Matching: s
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Preven The Business Journal Phoenix:  Aug 28 2008 12:39PM Matching: s
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Preven KLFY:  Aug 28 2008 12:38PM Matching: s
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Preven Cincinnati Business Journal:  Aug 28 2008 12:38PM Matching: s

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.